Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01WKR
|
||||
| Former ID |
DIB019806
|
||||
| Drug Name |
eGlu
|
||||
| Synonyms |
EGLU; (s)-alpha-ethylglutamate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [538877] | ||
| Formula |
C7H13NO4
|
||||
| InChI |
InChI=1S/C7H13NO4/c1-2-7(8,6(11)12)4-3-5(9)10/h2-4,8H2,1H3,(H,9,10)(H,11,12)/t7-/m0/s1
|
||||
| InChIKey |
QFYBYZLHPIALCZ-ZETCQYMHSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Metabotropic glutamate receptor3 | Target Info | Antagonist | [525820] | |
| Metabotropic glutamate receptor 2 | Target Info | Antagonist | [525820] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Ionotropic glutamate receptor pathway | |||||
| Metabotropic glutamate receptor group II pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Metabotropic glutamate receptor group II pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.